HEPATOCELLULAR CANCER

This study is testing whether adding an experimental drug called Q702 to an existing immunotherapy (pembrolizumab) can help control advanced cancers that have stopped responding to previous treatments. The trial will enroll 120 people with advanced esophageal, stomach, liver, or …

This study is testing whether a combination of three immunotherapy drugs, with or without a targeted liver procedure called TACE, can help control advanced liver cancer. The goal is to see if this approach can stop the cancer from getting worse for at least six months and help pe…

This study aimed to test if a personalized immune cell therapy could prevent or delay the return of advanced gastrointestinal cancers (like pancreatic, liver, or colon cancer) after standard treatment like surgery. It was for patients whose cancer had specific genetic mutations a…

This study is testing a new blood test called Oncoguard™ Liver to see how well it can find liver cancer early in people at high risk. It will compare the test's accuracy to standard ultrasound screening. The goal is to see if this blood test can be a reliable tool for monitoring …

This study is observing 10,000 adults with liver cancer over time to understand how the disease naturally progresses and how different treatments work in real-world doctor's offices and hospitals. It is not testing a new drug but is collecting information to build a large registr…